Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: luis a. garcia who wrote (792)	1/5/1998 12:47:00 AM
From: joco	Read Replies (1) \| Respond to of 1115

luis: I am just wondering why Bristol Meyers let this "great opportunity" go. Do they know something we don't. Seems very strange!

To: luis a. garcia who wrote (792)	1/5/1998 6:20:00 PM
From: James Silverman	Read Replies (1) \| Respond to of 1115

>>said David H. Katz, M.D., president and CEO of LIDAK. ''In particular, I want to express my profound appreciation to the LIDAK team which assembled this application in apparently record time. This NDA is the culmination of an intensive research and clinical development program of many years' duration>> Luis- Read this closely. Starts with "apparent" record time. Ends with "many years duration." The NDA was filed 4 months after the trial results were in and reported. I'm not sure what "apparent record" he's referencing. Apparently this is just another vague statement thats tough to make sense of. My brief takes on the recent events: The BMY drop. Not surprising at all. Amongst other reasons, I would speculate its largely because the market potential here is below BMY thresholds. You can foolishly speculate this is a $1B drug or even $500M, $100M for that matter but that would be fools play. LDAK needs a partner to market this-don't look for another major pharma to step forth-if anyone does have interest, look for it to be a second tier player-WPI, FRX, Swarz, maybe even LGND/AGPH or other biotech AIDS players that are developing their own marketing. The filing barely beat the year end. My take is the FDA will formally accept the filing as complete in 2 months-or late Feb. (reference GELX in todays news for timing) The formal announcement on its verdict should come in the first quarter of 1999.